| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/17/1997 | US5639777 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders |
| 06/17/1997 | US5639775 4-[4'-piperodinyl or 3'-pirrolidinyl] substituted imidazoles as H3 -receptor antagonists and therapeutic uses thereof |
| 06/17/1997 | US5639772 Administering 3-amino-5-carbamoyl-chromenes and derivatives for treatment of 5-hydroxytryptamine mediated disorders of central nervous system |
| 06/17/1997 | US5639766 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 06/17/1997 | US5639764 2-[(4-heteroaryl)-1-piperidinyl)alkyl]-1,3-indandiones and related compound and their therapeutic utility |
| 06/17/1997 | US5639760 Useful as muscle relaxants, sedatives, anxiolytics, anticonvulsants, and antidotes for drug overdose |
| 06/17/1997 | US5639752 Serotonin agonist |
| 06/17/1997 | US5639729 Tripeptides useful in immune and CNS therapy |
| 06/17/1997 | US5639652 Nucleic acid encoding serotonin |
| 06/17/1997 | US5639638 DNA molecules encoding bone morpogenetic protein-11 |
| 06/17/1997 | US5639634 Useful for diagnosing tumors and targeting drug delivery |
| 06/17/1997 | US5639472 Percutaneous absorption preparation |
| 06/17/1997 | US5639275 Capsule containing genetically engineered cells |
| 06/12/1997 | WO1997020850A1 3,4-DIHYDRO[1,2,4]THIADIAZINO[3,4-b]BENZOTHIAZOLE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 06/12/1997 | WO1997020847A1 Tricyclic ibogaine analogs, their preparation and their use in treating substance abuse |
| 06/12/1997 | WO1997020842A1 Novel purine derivatives having, in particular, antiproliferative properties, and biological uses thereof |
| 06/12/1997 | WO1997020836A1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutical use thereof |
| 06/12/1997 | WO1997020811A1 Vitamin d analogues |
| 06/12/1997 | WO1997020561A1 Composition for treating pain |
| 06/12/1997 | WO1997020558A1 Use of 2-iminobenzothiazolines for treating parkinson's disease and parkinsonian syndromes |
| 06/12/1997 | WO1997020557A1 Use of 2-aminobenzothiazoles for treating parkinson's disease and parkinsonian syndromes |
| 06/12/1997 | WO1997020556A1 Method for treating pain |
| 06/12/1997 | WO1997020554A1 Treatment of the cns effects of hiv with vx-478, alone or in combination with azt or 3tc |
| 06/12/1997 | WO1997020553A1 Treatment of negative and cognitive symptoms of schizophrenia with glycine uptake antagonists |
| 06/12/1997 | WO1997020552A1 Treatment of negative and cognitive symptoms of schizophrenia with glycine and its precursors |
| 06/12/1997 | CA2239732A1 Method for treating pain |
| 06/12/1997 | CA2238815A1 Composition for treating pain |
| 06/12/1997 | CA2238524A1 Tricyclic ibogaine analogs, their preparation and their use in treating substance abuse |
| 06/12/1997 | CA2238471A1 Treatment of the cns effects of hiv with vx-478, alone or in combination with azt or 3tc |
| 06/12/1997 | CA2192281A1 Heterocyclylcarbonyl substituted benzofuranyl-ureas |
| 06/11/1997 | EP0778277A1 Substituted heterocyclic derivatives as CRF antagonists |
| 06/11/1997 | EP0778275A1 Process for the preparation of imidazole, triazole and tetrazole derivatives and their use as selective 5-HT-1 receptor agonists |
| 06/11/1997 | EP0778266A1 5-Amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of beta-amyloid protein production |
| 06/11/1997 | EP0778025A1 Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of diseases caused by free radicals |
| 06/11/1997 | EP0778023A1 Neuroprotective agents |
| 06/11/1997 | EP0777740A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
| 06/11/1997 | EP0777739A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 06/11/1997 | EP0777686A1 Trophic factors for central nervous system regeneration |
| 06/11/1997 | EP0777684A1 Calcitonin receptor |
| 06/11/1997 | EP0777671A1 Spiro-azabicyclic compounds useful in therapy |
| 06/11/1997 | EP0777663A1 Use of substituted 6-amino-4h-pyrans |
| 06/11/1997 | EP0777660A1 Novel alkylamino derivatives as sigma 2 selective ligands |
| 06/11/1997 | EP0777659A1 Morpholine derivatives and their use as therapeutic agents |
| 06/11/1997 | EP0777653A1 Dihygropyridine derivatives as bradykinin antagonists |
| 06/11/1997 | EP0777652A1 Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkanol derivatives |
| 06/11/1997 | EP0777650A1 Biphenylamide derivatives as 5ht 1d? antagonists |
| 06/11/1997 | EP0777649A1 N- 2-(pyrrolidinyl-1)-1-phenylethyl]acetamides as kappa receptor antagonists |
| 06/11/1997 | EP0777493A1 Calcitonin gene related peptide receptor |
| 06/11/1997 | EP0777488A1 Composition and method for allogeneic mononuclear cell immunotherapy |
| 06/11/1997 | EP0777481A1 Use of n-substituted phenothiazines |
| 06/11/1997 | EP0777479A1 Dioxolenylmethyl carbamates promoieties for amine drugs |
| 06/11/1997 | EP0777478A1 Inhibitors of rotamase enzyme activity |
| 06/11/1997 | EP0777477A1 Improved pharmaceutical formulations containing ibuprofen and codeine |
| 06/11/1997 | EP0777473A1 Compositions and methods for the control of smoking |
| 06/11/1997 | EP0777471A1 Inhibition of leukotriene biosynthesis with urea derivatives |
| 06/11/1997 | EP0703913B1 Imidazoles as lipoxygenase inhibitors |
| 06/11/1997 | EP0557305B1 (2-thienyl) alkylamine derivatives having neuroprotective properties |
| 06/11/1997 | CN1151758A Novel growth of differentiation factor of the TGF- 'beta' family |
| 06/11/1997 | CN1151735A Benzocycloalkylazolethione derivatives |
| 06/11/1997 | CN1151729A Aryl and heteroaryl alkoxynaphtalene derivatives |
| 06/11/1997 | CN1151700A Tri-, tetra-, penta- and polypeptides and their therapeutic use as an antidepressant agent |
| 06/11/1997 | CN1151304A Pure and Natural intelligence enhancing agent |
| 06/10/1997 | US5637768 Process for making (2S,5S)-5-fluoromethylornithine |
| 06/10/1997 | US5637712 Process of preparing isoquinoline compounds |
| 06/10/1997 | US5637710 Intermediate compounds in the synthesis of heteroarylpiperidines and piperazines |
| 06/10/1997 | US5637697 1,5-benzodiazepine derivatives and their use in medicine |
| 06/10/1997 | US5637623 Substituted adamantyl guanidines and methods of use there of |
| 06/10/1997 | US5637611 Vasoconstructive agents; migraine |
| 06/10/1997 | US5637609 2-phenylpyrrole derivatives as dopamine D3 receptor antagonists |
| 06/10/1997 | US5637602 Nervous system disorders; gastrointestinal disorders |
| 06/10/1997 | US5637600 Phenylpyrrole derivatives and their use as dopamine D3 antagonists |
| 06/10/1997 | US5637596 Reacting aminomethylindole derivative with a carbonyl containing cyclizing agent; 5-ht3 receptor atagonist; useful for treating anxiety, psychosis, gut motility disorder, emesis, migraine and drug addiction |
| 06/10/1997 | US5637593 Tryptamine analogues as 5-ht1-like agonists |
| 06/10/1997 | US5637586 Angiotensin inhibitor; hypotensive agent |
| 06/10/1997 | US5637572 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis |
| 06/10/1997 | US5637571 Use of lignan derivatives for the preparation of pharmaceutical compositions for the treatment of states of amyloidosis |
| 06/10/1997 | US5637470 Screening array using cells expressing recombinant α and β subunits of the mammalian large-conductance (maxi-K) potassium channel |
| 06/10/1997 | US5637320 Controlled absorption naproxen formulation for once-daily administration |
| 06/08/1997 | CA2192298A1 Neuroprotective agents |
| 06/06/1997 | CA2191924A1 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of .beta.-amyloid protein production |
| 06/05/1997 | WO1997019942A1 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 06/05/1997 | WO1997019929A1 Polycyclic compounds |
| 06/05/1997 | WO1997019914A1 Amino acid derivatives, medicaments containing said compounds and methods of producing said compounds |
| 06/05/1997 | WO1997019695A1 Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 06/05/1997 | WO1997019686A1 Use of a combination of pentoxifylline and type i interferons for treating multiple sclerosis |
| 06/05/1997 | WO1997012583A3 Stable compositions containing n-propargyl-1-aminoindan |
| 06/05/1997 | WO1997009973A3 Peripherally active anti-hyperalgesic opiates |
| 06/05/1997 | DE19544686A1 Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Amino acid derivatives, medicaments containing these compounds and processes for their preparation |
| 06/05/1997 | CA2238770A1 Use of a combination of pentoxifylline and type i interferons for treating multiple sclerosis |
| 06/05/1997 | CA2191835A1 Use of 8,9-dehydroestrone as an antioxidant |
| 06/04/1997 | EP0776899A1 Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides |
| 06/04/1997 | EP0776898A1 Process improvement in the synthesis of N-[3-(3-cyanopyrazolo [1,5-a]pyrimidin-7-yl)phenyl]-N-ethyl-acetamide |
| 06/04/1997 | EP0776893A1 Azaheterocyclic compounds having tachykinin receptor antagonist activity; Nk1 and NK2 |
| 06/04/1997 | EP0776666A2 Analgesic anti-inflammatory drug |
| 06/04/1997 | EP0776339A1 Mhc complexes and uses thereof |
| 06/04/1997 | EP0776333A1 Peptide antagonist intermediates of neurotensin |
| 06/04/1997 | EP0776332A1 NEW PEPTIDE DERIVATIVES WITH $g(d) OPIOID RECEPTOR ANTAGONIST OR MIXED $g(m) AGONIST/$g(d) ANTAGONIST EFFECTS |
| 06/04/1997 | EP0776323A1 Salts of an anti-migraine indole derivative |
| 06/04/1997 | EP0776215A1 Device for delivery of substances and methods of use thereof |
| 06/04/1997 | EP0776201A1 Composition and method for treating anxiety |